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Supplementary Figure 3. Activity measurements with periplasmic extracts. (a)
Periplasmic extracts were obtained by osmotic shock as previously described 21 from E. coli JM109 cells expressing either BcII or BcII-Cys221Asp and initial velocities of cefotaxime hydrolysis at saturating substrate concentration were measured. Reaction mediums were: Hepes 15 mM pH 7.5, NaCl 200 mM, at 30°C, previously stirred with Chelex 100, and the same supplemented with 20 µM ZnCl 2 . This was repeated with three different periplasmic preparations, error bars represent mean values ± s.d. (b) Quantification of enzyme levels on the periplasmic extracts. Periplasmic extracts and known quantities of purified proteins were loaded on 12 % SDS-PAGE gels and Western blot assays were performed. Measuring the IOD of each band allowed to estimate a concentration of approximately 2 nM for the activity measurements. a b
Supplementary Figure 4. Zn II binding affinities for apo-BcII and apo-BcII-Cys221Asp determined by competition assays with PAR (4-(2-pyridylazo)-resorcinol).
Increasing concentrations of apo-portein were added to solutions of [Zn]= 1.5 µM and [PAR]= 12 µM or [PAR]= 6 µM. The increase of absorbance at 414 nm reflects the release of free PAR and the decrease of absorbance at 500 nm reflects the disappearance of the (PAR) 2 
Supplementary Methods
Plasmid construction and site-directed mutagenesis
The megaprimer method 2 was used to introduce the Cys221→Asp mutation. The mutagenic primer was 5'-GTTGGAGGCGATTTAGTGAAGTCGACGTCC-3'introducing a Cys221→Asp mutation (bold) and also a silent mutation introducing a Sal I restriction site (underlined). The external primers were 5'-CTATAAAAATAGGCGTATCACGAGG-3' (used in the first PCR) and 5'-GTACTTGTGGATTCTTCTTGGGATG-3' (used in the second PCR). The plasmid containing the wild-type bcII gene (pETLIInew) was used as DNA template. Polymerase chain reactions were run using Pfu DNA polymerase (Promega). All plasmids sequences used in this work were checked by restriction patterns and DNA sequencing.
Determination of minimal inhibitory concentrations
The minimal inhibitory concentrations (MICs) for ampicillin and cefotaxime were determined by the standard agar macro dilution method. . Then, the plates were incubated overnight at 37 °C.
Periplasmic extracts and Western blot analysis
E. coli JM109 cells transformed with pKP (negative control), pKP-BcII or pKP-BcIICys221Asp vectors were used to evaluate the periplasmic wild-type BcII or BcII-Cys221Asp levels by Western blot, as it was described previously. 6 Periplasmic extracts were obtained by isosmotic shock with lyzozyme and the total proteins were resolved by 12% SDS-PAGE. The proteins were transferred to a nitrocellulose membrane and the wild-type BcII or BcII-Cys221Asp proteins were identified by rabbit polyclonal antibodies against BcII as described by
Orellano et al. 3 The reactivity of the anti-BcII polyclonal antibodies was tested for both proteins by using different amounts of purified protein and measuring the intensity of each band by densitometry. The Integrated Optical Density (IOD) of each band was normalized to the band with 62.5 ng in the same assay (internal control).
Activity measurements with periplasmic extracts
Traditional methods of periplasmic purification commonly use lysozyme and EDTA. These protocols cannot be applied to our system if activity is to be measured, since the presence of the chelating agent alters the metal content of the enzyme and, consequently, the enzyme activity.
Therefore, we employed an alternative protocol to prepare periplasmic fractions, avoiding the use of EDTA and lysozyme 21 . Briefly, 5 ml of induced cell culture expressing wt BcII or BcIICys221Asp at OD 1.5 were first resuspended in 30 mM Tris, 20 % sucrose buffer (pH 8.0), and then were subjected to osmotic shock with 2 ml of cold 5 mM Periplasmic extracts were concentrated 20-fold with Amicon Ultra centrifugal filters MWCO10 kDa and 15 µl were loaded on SDS-PAGE gels, known quantities of purified proteins were loaded for calibration. Based on quantification from Western blot assays, the final enzyme concentration to measure activity on the cuvette was approximately 2 nM.
Protein expression, purification and sample preparation
BcII-Cys221Asp was expressed and purified following the protocol for wild-type BcII, 3 using the pETBcII-Cys221Asp-Term expression vector. Apo-enzymes and cobalt derivatives were prepared as previously reported by us. 7 Protein samples were quantified spectrophotometrically, using a molar extinction coefficient of 30,500 M -1 cm -1 . 10 and Δε 485nm = 17,420 M -1 cm -1 (nitrocefin) 11 . All the antibiotics used were from SIGMA, with the exception of Imipenem (USP Pharmacopeia) and Nitrocefin (OXOID), and all of them had a purity > 95%.
Reported kinetic parameters correspond to the average of at least three replicates  s.d.
Zn titration of purified enzymes followed by activity and estimation of K act
The initial velocities measurements for cefotaxime 200 μM were determined spectrophotometrically for wild-type BcII and BcII-Cys221Asp in the presence of increasing concentration of added ZnCl 2 (from an atomic standard absorption solution). Aliquots from stocks of 60 μM holo-enzyme or apo-enzyme diluted to 2 nM were used to initiate the reaction.
Reaction medium was 15mM Hepes pH 7.5, 200 mM NaCl at 30 ºC, previously stirred with Chelex 100. Differential molar extinction coefficients for antibiotic hydrolysis: Δε 262nm = -7,500
There were no differences between experimental points performed with holo or apo-enzymes stocks, since equilibrium is established once the protein is diluted. The initial velocities values were relativized to the value at 100 μM ZnCl 2 (considered as the maximum activity). The experimental data was fit to one Zn II binding event that accounts for the enzymes activation, and activation constants (K act ) were determined using the DynaFit software 12 .
Active Species  Inactive Species + Zn II K act
Metal binding affinities measured by competition with 4-(2-pyridylazo)-resorcinol (PAR)
The dissociation constants were estimated from competition experiments with the chromophoric chelator 4-(2-pyridylazo)-resorcinol (PAR; from Sigma). The indicator was first titrated with Zn II at 25 °C, and changes in absorbance at 414 nm (absorption maxima for PAR) and 500 nm (absorption maxima for the complex PAR 2 (Zn)) were fit with DynaFit software 12 to obtain the dissociation constant of Zn II from the complex with PAR (PAR 2 Zn) in 40 mM MOPS, and K d2 (K dPAR2Zn was fixed to the value determined previously):
BcII-Zn  apoBcII + Zn K d1
BcII-Zn 2  BcII-Zn + Zn K d2
For wild-type BcII, as K d1 could not be determined accurately, a model with its value fixed at 10 nM (Model II) was also tested to analyze the possibility of cooperative binding. Temperature was kept at 25 °C with a Lauda RC-6 water circulator. This procedure was repeated iteratively until activity reached a plateau value. Finally, the corresponding corrections for dilution effects were applied. , the limiting reagent in these conditions. The same holds true for the condition at 2.8 Co II eq, ie., the di-Co II species concentration is the same as that of the apoprotein, the limiting reagent in this case. Each enzyme sample was rapidly mixed in a 1:1 ratio with a solution of 5 mM imipenem, resulting in mixture of 163 μM for both mono-and diCo II species, and 2.5 mM imipenem. Absorption spectra were then recorded for a path-length of 0.2 cm, and stored for data processing.
Activity against imipenem of mono-and di-Co
Determination of crystal structures
BcII-Cys221Asp mutant crystals were grown using the hanging-drop vapor-diffusion method, in VDX multi-well (Hampton) plates with 300 µl reservoir solutions. Single crystals grew after a period of two weeks at 20°C. The reservoir solution contained 0.1 M sodium acetate Diffraction data was collected in the D03B-MX1 beamline at LNLS (Campinas, Brazil), and processed with HKL2000 13 and the CCP4 Suite of programs. 14 
Differentiation of apo, mono and dimetallic forms of BcII and Cys221Asp-BcII mutant
The apo forms of each protein were prepared by dialysis against chelating agents as previously described. 7 Different aliquots of these samples in their apo forms were supplemented with 1 or 2 equivalents of Zn 
